Notes to SEFA
Title: BASIS OF PRESENTATION
Accounting Policies: EXPENDITURES REPORTED ON THE SCHEDULE ARE REPORTED ON THE ACCRUAL BASIS OF ACCOUNTING. SUCH EXPENDITURES ARE RECOGNIZED FOLLOWING THE COST PRINCIPLES CONTAINED IN UNIFORM GUIDANCE, WHEREIN CERTAIN TYPES OF EXPENDITURES ARE NOT ALLOWED OR ARE LIMITED AS TO REIMBURSEMENT. PASS-THROUGH ENTITY IDENTIFYING NUMBERS ARE PRESENTED WHERE AVAILABLE.
De Minimis Rate Used: N
Rate Explanation: MERIDIAN HEALTHCARE DID NOT ELECT TO USE THE 10 PERCENT DE MINIMIS INDIRECT COST RATE ALLOWED UNDER THE UNIFORM GUIDANCE.
THE ACCOMPANYING SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS (THE "SCHEDULES") INCLUDES THE FEDERAL GRANT ACTIVITY OF MERIDIAN HEALTHCARE UNDER THE PROGRAMS OF THE FEDERAL GOVERNMENT FOR THE YEAR ENDED JUNE 30, 2023. THE INFORMATION IN THIS SCHEDULE IS PRESENTED IN ACCORDANCE WITH THE REQUIREMENTS OF TITLE 2 U.S. CODE OF FEDERAL REGULATIONS PART 200 UNIFORM ADMINISTRATIVE REQUIREMENTS , COST PRINCIPLES, AND AUDIT REQUIREMENTS FOR FEDERAL AWARDS (UNIFORM GUIDANCE). BECAUSE THE SCHEDULE PRESENTS ONLY A SELECTED PORTION OF THE OPERATIONS OF THE COMPANY, IT IS NOT INTENDED TO AND DOES NOT PRESENT THE FINANCIAL POSITION, CHANGE IN NET ASSETS AND CASH FLOWS OF MERIDIAN HEALTHCARE.
Title: RECONCILIATION OF FEDERAL AWARDS
Accounting Policies: EXPENDITURES REPORTED ON THE SCHEDULE ARE REPORTED ON THE ACCRUAL BASIS OF ACCOUNTING. SUCH EXPENDITURES ARE RECOGNIZED FOLLOWING THE COST PRINCIPLES CONTAINED IN UNIFORM GUIDANCE, WHEREIN CERTAIN TYPES OF EXPENDITURES ARE NOT ALLOWED OR ARE LIMITED AS TO REIMBURSEMENT. PASS-THROUGH ENTITY IDENTIFYING NUMBERS ARE PRESENTED WHERE AVAILABLE.
De Minimis Rate Used: N
Rate Explanation: MERIDIAN HEALTHCARE DID NOT ELECT TO USE THE 10 PERCENT DE MINIMIS INDIRECT COST RATE ALLOWED UNDER THE UNIFORM GUIDANCE.
THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, OR HHS, ESTABLISHED THE PROVIDER RELIEF FUND (PRF) TO SUPPORT ELIGIBLE HEALTH CARE PROVIDERS IN THE BATTLE AGAINST THE COVID-19 PANDEMIC. SUCH FUNDS ARE SUBJECT TO CERTAIN TERMS AND CONDITIONS, INCLUDING CERTAIN REPORTING REQUIREMENTS, BASED ON THE DISTRIBUTION PERIOD AND DEADLINE TO USE FUNDS. THE COMPANY RECEIVED PERIOD 4 FUNDING IN FISCAL YEAR 2022, AND SUCH FUNDS WERE REPORTED IN THE FISCAL YEAR 2023 SCHEDULE OF FEDERAL AWARDS, AS PER THE COMPLIANCE SUPPLEMENT. THE FOLLOWING IS A RECONCILIATION OF FEDERAL AWARDS BETWEEN THE STATEMENT OF ACTIVITIES AND THE SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS (SEFA) AS OF JUNE 30, 2023: TOTAL FEDERAL GRANTS PER STATEMENT OF ACTIVITIES $2,620,201; PERIOD 4 PROVIDER RELIEF FUNDS NOT REPORTED ON SEFA IN FY22 $219,232; TOTAL EXPENDITURES OF FEDERAL AWARDS PER SEFA $2,839,433.